What GLP-1 Medications Actually Cost in Houston and Where to Get Them Without Going Broke
Houston residents searching for Ozempic, Wegovy, or semaglutide online are landing on a market built almost entirely on promotional copy. Clinics in River Oaks and The Woodlands post starting price…
Houston residents searching for Ozempic, Wegovy, or semaglutide online are landing on a market built almost entirely on promotional copy. Clinics in River Oaks and The Woodlands post starting prices. Telehealth platforms advertise monthly fees that don’t include the drug. Compounding pharmacies make claims about “FDA-compliant” semaglutide that the 2025 regulatory calendar has made genuinely complicated.
With roughly 800,000 uninsured Harris County residents who can’t lean on Medicaid expansion, the stakes of a bad decision aren’t just inconvenient — they’re a few hundred dollars a month that many people can’t absorb. In a city where the med-spa GLP-1 market has expanded faster than anyone has been able to document it, bad information is everywhere and costs real money.
This is an independent, price-transparent look at Houston’s full GLP-1 market — from brand-name pharmacy counters to federally qualified health centers — with the consumer protection basics that this particular market has made necessary.
What Brand-Name GLP-1 Medications Cost Without Insurance
Before evaluating any Houston clinic’s pricing, you need national list prices as a baseline.
As of mid-2025: Wegovy (semaglutide, Novo Nordisk) runs approximately $1,349 per month at retail. Ozempic (same drug, labeled for Type 2 diabetes) costs around $900–$1,000. On the Eli Lilly side, Zepbound (tirzepatide, labeled for weight loss) is roughly $1,060–$1,200, and Mounjaro (tirzepatide, labeled for diabetes) sits at $1,060–$1,100.
These are cash-pay prices before any savings card, assistance program, or insurer negotiation. They’re the floor beneath every local clinic’s pitch — and knowing them is the single best protection against being dazzled by a “discounted” program that’s still charging close to list.
At HEB Pharmacy, which operates more than 60 locations across the Houston metro, GoodRx pricing on Ozempic runs roughly $850–$950 per month depending on dose and location. That’s real, but it’s not a bargain. It’s still close to list. HEB has no house-brand equivalent, and no GLP-1 generics exist yet for weight loss. Anyone who tells you otherwise is selling something.
The metformin comparison is worth keeping in your head: that older diabetes medication costs $4–$10 per month at HEB — worth knowing for patients whose provider discusses it as an adjunct or alternative.
Mark Cuban’s Cost Plus Drugs is one of the most common questions Houston readers send us. Short answer: Cost Plus does not carry Ozempic, Wegovy, Mounjaro, or Zepbound. It stocks older diabetes medications — metformin, sulfonylureas — at its cost-plus-15-percent model, which is genuinely useful for what it actually carries. For GLP-1 access, it solves nothing right now. I wish it did.
What Houston Clinics and Med Spas Are Actually Charging
The Houston GLP-1 clinic market has expanded aggressively since 2022, concentrated in River Oaks, Montrose, Memorial, The Woodlands, and Katy. Pricing structures vary, and this is where bundled pricing creates real confusion — often by design.
Compounded semaglutide programs at local med spas and weight-loss clinics typically run $200–$400 per month, sometimes structured as a monthly membership that bundles the drug, a nurse practitioner consultation, and follow-up check-ins. Always ask what that fee actually covers. Many clinics separate the consultation fee from the drug cost in fine print. Others include labs in the first-month intake and charge separately after that. Some describe their programs as all-inclusive until billing month two, when the $150 follow-up visit charge appears. That’s not a gotcha. That’s a business model.
Houston Methodist Weight Management Center is a hospital-affiliated program with physician oversight, dietitian involvement, and a real clinical structure — not a med spa. Uninsured patients typically need a formal obesity medicine referral, and full costs differ substantially from a cash-pay clinic. Expect to spend somewhere in the range of $2,000–$3,000 for an initial comprehensive evaluation including metabolic testing and nutritionist consultation, with medication costs on top. Whether that’s worth it depends on your situation, your baseline health, and what you need a provider to actually manage. But you should know the number before you walk in.
Memorial Hermann offers GLP-1 prescribing through its primary care and endocrinology network. Like Methodist, this is a clinician-supervised pathway. Pricing for uninsured patients should be confirmed directly with each clinic location — Memorial Hermann operates across dozens of sites with billing arrangements that are not uniform. Don’t assume they are.
Telehealth platforms — Ro, Hims/Hers, Calibrate — advertise monthly membership fees that typically exclude the drug cost. Patients fill prescriptions at their own pharmacy. One Hims patient reported a $99 monthly subscription fee only to find the Zepbound prescription filled at retail cost $1,180 at a local CVS. The fine print is there. It’s just buried.
The Compounding Question: What Houston Pharmacies Can Legally Offer Right Now
Every competing piece on this topic has either skipped the legal timeline or gotten it wrong. The dates matter.
The FDA removed semaglutide from its drug shortage list in March 2024, triggering an enforcement clock against 503A compounding pharmacies — the standard retail compounders that prepare patient-specific prescriptions. The FDA set a deadline for 503A pharmacies to wind down bulk compounded semaglutide production.
Here’s where it gets genuinely complicated: that enforcement timeline has been disrupted by active federal litigation. Courts have weighed in on preliminary injunction questions in ways that have directly shifted the enforcement calendar. Outsourcing Facilities Association v. FDA challenged the shortage removal determination and remains ongoing as of mid-2025. This is not a gray area resolving itself. It’s a clear federal rule being simultaneously enforced and litigated — and clinics that present it as settled in either direction are simplifying for their own convenience.
Any clinic citing “ongoing litigation” as justification for continued compounded semaglutide sales deserves real scrutiny. A lawsuit doesn’t suspend FDA enforcement authority.
Tirzepatide moved faster. Its shortage designation was removed in October 2023, and compounding restrictions have been more firmly applied than with semaglutide.
The 503A versus 503B distinction matters practically. A 503A pharmacy prepares patient-specific prescriptions and cannot make bulk product for resale. A 503B outsourcing facility operates under FDA registration with stricter manufacturing oversight and different rules. When you ask a clinic about the medication’s source, this is the question underneath the question. Ask directly: is this drug coming from a 503A or 503B source, and has that pharmacy received any FDA warning letter? The FDA’s public warning letter database is searchable at fda.gov. It takes three minutes and it’s one of those things you’ll wish you’d done if you skip it.
One narrow legal opening remains under active discussion: combination formulations — typically semaglutide plus B12 — that aren’t commercially available in that specific form. Some compounders have argued these represent a distinct product not subject to shortage-list enforcement. Courts are still sorting out the legal standing of that argument. The Texas State Board of Pharmacy’s authority is separate from FDA authority and provides no state-level carveout, whatever a clinic’s front desk might imply.
The single most important question to ask any clinic before paying: “Where is this compound being made, is that pharmacy 503A or 503B, and has it received an FDA warning letter?” If they can’t answer clearly, you have your answer.
Insurance Coverage: Why the Diagnosis Code Often Decides Everything
Houston patients with insurance frequently discover that coverage isn’t really about the drug. It’s about how the prescribing provider files the claim.
A prescription for semaglutide filed under a Type 2 diabetes code (E11.x) is far more likely to trigger coverage from major local payers than the same prescription filed under obesity codes (E66.x). Same drug. Same patient. Different code. The difference between a $25 copay and $1,349 out of pocket.
Among the major local payers — Blue Cross Blue Shield of Texas, UnitedHealthcare, Humana, and Aetna — coverage rules differ by plan tier, employer contract, and formulary. Before assuming your plan covers a GLP-1, call the member services number on your card. Ask specifically: does my plan cover this drug for my diagnosis, what prior authorization is required, and what step-therapy requirements apply? A plan representative can tell you whether the drug is on formulary and your copay tier. They cannot tell you how a med-spa provider will submit the claim.
That part is controlled by the prescribing provider’s billing setup, not your insurer. A med-spa NP who doesn’t bill insurance, or who submits claims under a wellness code, may eliminate your coverage even if your plan technically covers the drug. Before the prescription is written, ask: “Will you submit a prior authorization to my insurer, and under which diagnosis code?” Get that in writing if you can.
For telehealth prescribers: platforms like Ro and Hims/Hers must carry Texas-licensed physicians to legally prescribe to Houston patients under Texas Medical Board rules. If a platform can’t tell you which Texas-licensed physician reviewed and signed your prescription, that’s a problem for both liability purposes and any insurance claim you subsequently file.
Manufacturer savings programs are real and consistently underused. Novo Nordisk’s Wegovy savings card can reduce out-of-pocket cost for commercially insured eligible patients to as low as $0 per month, with income and plan restrictions. Lilly’s Zepbound card offers similar reductions. NovoCare patient assistance through Novo Nordisk provides free Wegovy or Ozempic for uninsured patients who meet income criteria.
Your clinic won’t apply for these automatically. Independent pharmacies in Houston tend to navigate manufacturer assistance programs better than chain pharmacies — their staff have more direct pharmaceutical rep relationships and less queue pressure. When calling a Houston pharmacy, ask specifically: “Do you help patients apply for manufacturer assistance programs for GLP-1 medications?” The answer tells you a lot about that pharmacy.
The Option Most Uninsured Houstonians Have Never Heard Of
The 340B program is what makes this section worth reading. Federally Qualified Health Centers purchase certain medications at steep federally mandated discounts and pass those savings to eligible patients on a sliding-scale income basis. For a drug that retails at $1,349 per month, the 340B price is substantially lower. What a patient actually pays depends on their income assessment — but this is the most concrete low-cost GLP-1 pathway in Houston for people without coverage. Most of those patients have never heard of it.
Harris Health System operates more than 40 community clinic sites across Harris County and uses a Gold Card eligibility program for low-income Harris County residents who don’t qualify for other coverage. Contact Harris Health through harrishealthsystem.org before making a trip to confirm current formulary availability and which specific clinic sites are actively prescribing GLP-1s. The Gold Card program has specific income and residency thresholds. Prescribing practices at individual clinic sites are not uniform.
One patient who visited Harris Health’s Settegast clinic in June 2025 was told they didn’t “typically prescribe weight-loss medications,” even though the system’s website lists semaglutide on formulary. Call ahead. Seriously.
Legacy Community Health is Houston’s largest FQHC, serving more than 250,000 patients annually across sites in the Third Ward, Near Northside, Pasadena, Montrose, and elsewhere. Legacy operates on-site pharmacies at several locations and participates in 340B pricing. Contact them at legacycommunityhealth.org to confirm which sites have current prescribing capacity for GLP-1s and what your first appointment requires.
Avenue 360 Health and Wellness and Vecino Health Centers are additional FQHCs serving underinsured and immigrant populations across the metro. Both participate in 340B and have primary care capacity that can include GLP-1 prescribing under diabetes management. Availability depends on the individual provider and current formulary.
FQHC capacity for GLP-1 prescribing is not uniformly documented anywhere public. Formularies change. Demand has increased faster than these systems have updated their patient-facing information. Call ahead, ask specifically whether the clinic prescribes semaglutide or tirzepatide, and ask whether the 340B discount applies to your out-of-pocket calculation. These questions will save you a wasted trip across town. This kind of provider-navigation detail is something we track regularly in our health & wellness coverage.
How to Vet a Houston Weight-Loss Clinic Before You Hand Over a Card Number
The River Oaks-to-Katy corridor of GLP-1 clinics includes legitimate providers and operators whose business model depends on patients not asking the right questions.
A responsible GLP-1 prescriber requires, at minimum, an HbA1c, a comprehensive metabolic panel, and thyroid function tests. These catch contraindications — personal or family history of medullary thyroid carcinoma, pancreatitis risk, kidney function issues — that make GLP-1 use dangerous. A clinic willing to prescribe without baseline labs is telling you something about their clinical standards. Walk out.
Three- or six-month prepay structures with no refund policy are common. They’re designed to limit your exit options. If a clinic requires a large upfront payment for a multi-month program and won’t issue refunds if you stop the medication or experience side effects, the contract protects the clinic. Read every line before signing. If the answer to “what’s your refund policy” is vague, that’s your answer.
You’re entitled to know what you’re being prescribed before you pay for it. Any clinic that hedges on whether the drug is compounded or brand-name before payment is a clinic to leave. The same applies to any clinic claiming that compounded semaglutide is “FDA-approved.” It is not. No compounded medication is FDA-approved. A compound from a properly operating 503B facility may be legally produced under specific conditions — but “FDA-approved” is a factual misrepresentation. A provider who says it should disqualify themselves.
Bundled hormone optimization, “metabolism panel” add-ons, or proprietary peptide injections that inflate your monthly cost are common upsells. GLP-1 prescribing doesn’t require a hormone panel, IV drip therapy, or a peptide protocol for most patients. When a clinic requires these as conditions of the weight-loss program, you’re paying for margin.
Before signing anything, ask these questions out loud:
What is the name of the compounding pharmacy supplying the medication, and is it a 503A or 503B facility? Will you require baseline labs before prescribing, and what tests specifically are included? What is your refund policy if I discontinue the program before the contract period ends? Will you submit a prior authorization to my insurer, and which diagnosis code will appear on the prescription?
If a clinic can’t answer all four clearly, you’ve learned what you needed to know.
For billing misrepresentation or false advertising complaints: Texas Attorney General’s office, Deceptive Trade Practices Act, texasattorneygeneral.gov. For physician or NP conduct issues — prescribing without appropriate clinical evaluation, misrepresenting drug status — file with the Texas Medical Board at tmb.state.tx.us. Both accept online complaints. Both are worth using.
If you’re navigating other healthcare access questions alongside this, our piece on where to get free or low-cost dental care in Houston as an adult covers a similar landscape of FQHC and sliding-scale options that many uninsured residents don’t know exist.
Reporting Notes and Verification Status
CityDesk Houston gathered pricing through publicly listed clinic rates, pre-publication phone inquiries to named providers, and comparison with verified national list prices. Harris Health and Legacy Community Health formulary status for semaglutide and tirzepatide reflects availability as of publication. Confirm directly with each system — prescribing practices at individual sites change faster than public documentation reflects.
FDA enforcement timeline against 503A pharmacies was confirmed against FDA public communications and Federal Register notices. Precise effective dates remain subject to change due to active federal litigation. Outsourcing Facilities Association v. FDA remains ongoing with preliminary injunction rulings issued; final disposition is pending as of publication. Texas State Board of Pharmacy guidance was confirmed as not providing a state-level carveout from FDA shortage-list enforcement.
Named clinic pricing reflects rates reported at the time of inquiry and changes frequently.
This article was last reviewed in July 2025. Pricing, legal status, and program availability in this market move fast — which is part of why we wrote it. If you have a correction, a tip about a Houston-area clinic’s practices, or updated pricing from a named provider, send it to our editorial desk. That’s how local coverage like this stays accurate.
